8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $797M | $30M | 0.0% | 11.0% | $164M | $495M | $262M |
| 2024 | $792M | $16M | 0.0% | 8.3% | $183M | $500M | $448M |
| 2023 | $750M | -$9M | 0.0% | -3.6% | $137M | $656M | $672M |
| 2022 | $767M | -$33M | 0.0% | 0.2% | $143M | $667M | $757M |
| 2021 | $745M | -$25M | 0.0% | 1.8% | $174M | $674M | $941M |
| 2020 | $551M | -$294M | 0.0% | -50.1% | $111M | $681M | $969M |
| 2019 | $388M | $66M | 0.0% | 36.0% | $82M | $671M | $26M |
| 2018 | $250M | $44M | 0.0% | 31.0% | $44M | — | $35M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $194M | $1M | 0.0% | 7.2% | $11M | $487M | $236M |
| Dec '25 | $195M | $5M | 0.0% | 11.6% | $32M | $495M | $262M |
| Sep '25 | $196M | $1M | 0.0% | 7.5% | $74M | $489M | $274M |
| Jun '25 | $203M | $13M | 0.0% | 13.2% | $49M | $490M | $281M |
| Mar '25 | $203M | $11M | 0.0% | 11.5% | $9M | $491M | $301M |
| Dec '24 | $199M | $7M | 0.0% | 9.2% | $45M | $500M | $448M |
| Sep '24 | $195M | $4M | 0.0% | 10.5% | $86M | $491M | $424M |
| Jun '24 | $201M | $7M | 0.0% | 9.9% | $9M | $653M | $525M |
| Mar '24 | $198M | -$1M | 0.0% | 3.7% | $42M | $654M | $533M |
| Dec '23 | $197M | -$26M | 0.0% | -9.3% | $15M | $656M | $672M |
| Sep '23 | $180M | -$38M | 0.0% | -21.3% | $60M | $656M | $795M |
| Jun '23 | $190M | $59M | 0.0% | 9.7% | $30M | $657M | $762M |
| Mar '23 | $184M | -$3M | 0.0% | 6.1% | $32M | $658M | $761M |
| Dec '22 | $184M | -$2M | 0.0% | 0.9% | $32M | $667M | $757M |
| Sep '22 | $187M | -$42M | 0.0% | -8.4% | $33M | $660M | $729M |
| Jun '22 | $192M | -$1M | 0.0% | -2.1% | $50M | $661M | $731M |
| Mar '22 | $203M | $12M | 0.0% | 9.7% | $28M | $662M | $845M |
| Dec '21 | $213M | -$40M | 0.0% | 5.5% | $49M | $674M | $941M |
| Sep '21 | $195M | -$18M | 0.0% | 3.6% | $48M | $664M | $912M |
| Jun '21 | $177M | $31M | 0.0% | -0.2% | $35M | $665M | $895M |
How the market has priced GDRX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, GoodRx Holdings, Inc.'s revenue has grown 7.7% per year. These are computed facts, not advice.
As of FY2025, GoodRx Holdings, Inc. reported $495M of total debt against $262M of cash; operating income covered interest expense 2.1×.
In FY2025, gross margin was —, operating margin 11.0%, and net margin 3.8%.
As of Jun '26, GoodRx Holdings, Inc. traded at a price-to-earnings ratio of about 30.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.